卟啉

基本解释 (translations)

porphyrin

与卟啉相关的网络例句 [注：此内容来源于网络，仅供参考]

Chapter two: Using 5-(4-aminophenyl)-10,15,20-triphenylporphyrin as thestarting compound, the classical diazotization of aniline and the resulting reaction ofdiazo salts were applied to porphyrin for the first time, and a series of asymmetriclysubstituted meso-tetraarylporphyrins including 5-(4-chlorophenyl)-10,15,20-triphenylporphyrin, 5-(4-iodinphenyl)-10,15,20-triphenylporphyrin, 5-(4-cyanophenyl)-10,15,20-triphenylporphyrin, 5-(4-bisphenyl)-10,15,20-triphenylporphyrin and 5-(4-hydroxylphenyl)-10,15,20-triphenylporphyrin were synthesized.

第二章：在已合成的5-(4-氨基苯基)-10，15，20-三苯基卟啉基础上，首次将芳胺的重氮化及重氮盐反应应用于卟啉，合成了5-(4-氯苯基)-10，15，20-三苯基卟啉、5-(4-碘基苯基)-10，15，20-三苯基卟啉、5-(4-氰基苯基)-10，15，20-三苯基卟啉、5-(4-联苯基)-10，15，20-三苯基卟啉和5-(4-羟基苯基)-10，15，20-三苯基卟啉等一系列不对称取代的meso-四芳基卟啉。

In this thesis, a series of porphyrin derivatives were synthesized, for example, six porphyrin amphiphiles, one water-soluble porphyrin and one dyad of phenothiazine and porphyrin.

在本文中，我们合成了一系列的卟啉衍生物，包括六种两亲性卟啉、一种水溶性卟啉和一种卟啉—吩噻嗪二元化合物。

The metalloproteins which are widely distributed in vivo are very important target molecules of NO. A new Y/〓 reaction system which can form Y-NO bond has been established and has been used to measure the NO affinity of metalloporphyrins as metalloprotein models. Three kind of bond energies of the Co-NO bonds in series of cobalt nitrosyl tetraphenylporphyrins have been determined by thermodynamic cycles combined with calorimetric measurements and relevant electrochemical data.

本文以金属卟啉模拟体内重要的NO靶分子金属蛋白，通过确立新的适于量热和电化学测定的Y／〓成Y-NO键反应体系，利用合适的热力学循环，建立了新的适于金属卟啉体系的NO亲合势的测定方法，得到了苯腈中系列亚硝基四苯基钴卟啉Co-NO键的键能，即钴卟啉NO亲合势的定量标度，以表征钴卟啉的NO结合能力。

Three kind of bond energies of the Co-NO bonds in series of cobalt nitrosyl tetraphenylporphyrins have been determined by thermodynamic cycles combined with calorimetric measurements and relevant electrochemical data.

本文以金属卟啉模拟体内重要的NO靶分子金属蛋白，通过确立新的适于量热和电化学测定的Y／〓成Y-NO键反应体系，利用合适的热力学循环，建立了新的适于金属卟啉体系的NO亲合势的测定方法，得到了苯腈中系列亚硝基四苯基钴卟啉Co-NO键的键能，即钴卟啉NO亲合势的定量标度，以表征钴卟啉的NO结合能力。

The object of this study is to cancerous and normal cells intimacy of hematoporphyrin derivative for diagnosis and therapy cancer, fluorescence spectra of cancerous and normal cells are measured using a ultrashort pulses laser spectral technique and picosecond time-correlated single-photon counting system.

研究用于癌症诊断与治疗的光敏剂血卟啉(hematoporphyrin derivative， HPD)对人体癌细胞与正常细胞的亲和性，采用超短脉冲激光光谱技术和皮秒时间相关单光子计数系统，测量经血卟啉培养的活体癌细胞与正常细胞的荧光光谱，观测到癌细胞样品在创645nm处具有特有的光谱谱峰；测量不同浓度血卟啉荧光光谱，观测到随着血卟啉浓度的逐渐增大，在645nm处出现的光谱峰也随之显著增强。

Chromatographic behaviors of six cationic thulium porphyrin complexes have been firstly investigated in different mobile phase.

2首次以六个不同的铥卟啉配合物（四（4-羟基苯基）卟啉铥、四（4-甲氧基苯基）卟啉铥、四苯基卟啉铥、四（4-甲基苯基）卟啉铥、四（4-氯苯基）卟啉铥和四（4-异丙基苯基）卟啉铥）为研究对象进行HPLC分离。

Homogeneous catalytic oxidations of organic substrates such as alkane and alkene catalyzed by m-oxo-bismetalloporphyrins and flexible alkoxyl oxygen linked-bismetalloporphyrins were introduced,and the catalytic mechanism of these two bismetalloporphyrins,along with the possible synergetic catalysis mechanism of binuclear central metal were discussed.

主要介绍了μ-氧代双核金属卟啉和以柔韧烷氧链相连的双核金属卟啉作为仿酶催化剂在均相催化烷烃、烯烃等有机底物氧化方面的研究进展，并对这两类双核金属卟啉的催化机理、金属双核的协同催化作用机理作了论述，最后展望了双核金属卟啉仿酶催化剂的研究前景。

The behaviors of supramolecular self-assembly of cabboxyl porphyrin-anthraquinone systems, carboxyl porphyrin zinc-copper systems, porphyrinatozinc-imidazolyl tailed porphyrinatomanganese systems, porphyrinatozinc-anthraquinone hybrids/imidazolyl tailed porphyrinatomanganese systems and porphyrinatozinc-fluorescein hybrids/imidazolyl tailed porphyrinatomanganese systems driven by hydrogen-bonding or coordination-bonding have been studied.

设计、合成了多种新型羧基卟啉、卟啉-蒽醌二元化合物和卟啉-荧光素二元化合物，研究了氢键或配位键驱动的羧基卟啉-蒽醌、羧基卟啉锌-羧基卟啉铜、锌卟啉-咪唑基尾式卟啉锰二元超分子，卟啉-蒽醌二元化合物与咪唑基尾式卟啉锰三元超分子的构建和光诱导电子转移性质。

Eight porphyrin compounds, meso-5, 10, 15, 20-Tetra [4-aminophenyl] porphine (TAPPH〓, 1), meso-5, 10, 15, 20-Tetra [4-(N-pyrrolidinyl) phenyl] porphine (TBPPH〓, 2), meso-5, 10, 15, 20-Tetra [4-(4'-ethylpiperazinyl) phenyl] porphine (TEPPH〓, 3), meso-5, 10, 15, 20-Tetra [4-(4'-butylpiperazinyl) phenyl] porphine (TUPPH〓, 4), meso-5, 10, 15, 20-Tetra [4-(4'-heptylpiperazinyl) phenyl] porphine (TEPPH〓, 5), 5- [4-(4'-ethylpiperazinyl) phenyl] -10, 15, 20-triphenylporphine (MEPPH〓, 6), 5- [4-(4'-buthylpiperazinyl) phenyl] -10, 15, 20-triphenylporphine (MUPPH〓, 7) and N, N'-di (meso-5, 10, 15, 20-tetraphenylporphinato) piperazine (DiPPH〓, 8) have been designed and synthesized. These porphyrins are never reported except TAPPH〓.

设计并合成了8种卟啉化合物，分别为meso-5，10，15，20-四（4-氨基苯基）卟啉（TAPPH〓，1），meso-5，10，15，20-四卟啉（TBPPH〓，2），meso-5，10，15，20-四[4-（4'-乙基哌嗪基）苯基]卟啉（TEPPH〓，3），meso-5，10，15，20-四[4-（4'-丁基哌嗪基）苯基]卟啉（TUPPH〓，4），meso-5，10，15，20-四[4-（4'-庚基哌嗪基）苯基]卟啉（THPPH〓，5），5，10，15-三苯基-20-[4-（4'-乙基哌嗪基）苯基]卟啉（MEPPH〓，6），5，10，15-三苯基-20-[4-（4'-丁基哌嗪基）苯基]卟啉（MUPPH〓，7）和N，N'-二（meso-5，10，15，20-四苯基卟啉基）哌嗪（DiPPH〓，8）。

Using classical diazotisation of anilines, 5-(4-aminophenyl)-10,15,20-triphenyl-porphyrin was converted to a series of meso-tetraarylporphyrins with different substituents, including 5-(4-hydroxylphenyl)-10,15,20-triphenylporphyrin (80%), 5-(4-chlorophenyl)-10,15,20-triphenylporphyrin (74%), 5-(4-iodinphenyl)-10,15,20-triphenylporphyrin (76%), 5-(4-hydrazinephenyl)-10,15,20-triphenylporphyrin (67%) and 5-(4-bisphenyl)-10,15,20-triphenylporphyrin (32%). Therefore an efficient way of synthesizing unsymmetrically substituted TAPs was developed.

利用芳胺的重氮化及重氮盐反应，研究了5-(4-氨基苯基)-10，15，20-三苯基卟啉上氨基官能团的转化反应，以较高产率合成了5-(4-羟基苯基)-10，15，20-三苯基卟啉(80%)、5-(4-氯苯基)-10，15，20-三苯基卟啉(74%)、5-(4-碘基苯基)-10，15，20-三苯基卟啉(76%)、5-(4-肼基苯基)-10，15，20-三苯基卟啉(67%)和5-(4-联苯基)-10，15，20-三苯基卟啉(32%)等一系列含单个para-取代基的meso-四芳基卟啉，为合成不对称取代的芳基卟啉提供一条有效途径。

与卟啉相关的网络解释 [注：此内容来源于网络，仅供参考]

hematoporphyrin：血卟啉

40年代末Figge等[2]发现血卟啉(hematoporphyrin)可被淋巴结、肿瘤、胚胎或创伤组织摄取,当被紫外线照射后,能产生一种明亮的桔红色荧光. 1955年Rasmussen-Taxdal等[3]给10例恶性肿瘤患者静脉注射500~1 000 mg的血卟啉,发现8例患者肿瘤部位有荧光.

hematoporphyrin：血紫质 血卟啉

hematoporphyrin 血紫质 血卟啉 | hematoporphyrinemia 血紫质血 | hematoporphyrinism 血紫质病 慢性血卟啉症

porphyria：卟啉症

血红素合成代谢异常而引起卟啉化合物或其前身体的堆积,称为卟啉症(porphyria). 先天性红细胞生成性卟啉症(congenital erythropoietic porphyria)是由于先天性缺乏尿卟啉原Ⅲ同合酶,而使线状四吡咯向尿卟啉原Ⅲ的转变受阻,

porphyria：卟啉病

卟啉病(porphyria)是一种卟啉代谢紊乱的疾病,以尿中和粪中卟啉和卟啉前体排泄增多为特点. 卟啉病为先天性疾病,主要由于与血红素合成有关的各种酶缺乏所引起,有家族发病史.

porphyrin：卟啉

'''血红素'''('''Heme''')是一种含铁[[辅基]],铁原子位于被称为[[卟啉]] (porphyrin) 的大[[杂环化合物]]中心. 并非所有的卟啉分子中都含有铁,但含有卟啉的[[金属蛋白]]都以血红素为辅基,这些[[蛋白质]]即[[血红蛋白]].

porphyrin complex：卟啉络合物

porphin 卟吩 | porphyrin complex 卟啉络合物 | porphyrin 卟啉

protoporphyrin：原紫质/原卟啉

protoporphyria /原卟啉症/ | protoporphyrin /原紫质/原卟啉/ | protoptile /原始羽毛/

protoporphyrin fractionation：原卟啉组份

3J055 原卟啉 protoporphyrin | 3J056 原卟啉组份 protoporphyrin fractionation | 3J060 卟啉 porphyrin fractionation

erythropoietic porphyrin：生血性卟啉

erythropoietic porphyria 生血性卟啉症 | erythropoietic porphyrin 生血性卟啉 | erythropoietin 红细胞生成素

uroporphyrin：尿卟啉

HPD)1.1卟啉1.1.1卟啉的理化性质在人体中卟啉化合物是作为血红素生物合成的中间体而存在,在体内是以不具有紫色荧光的还原型卟啉原形式存在,但在空气中卟啉原会自动氧化成卟啉. 正常健康人体内主要存在尿卟啉(uroporphyrin)